Home > Research > Publications & Outputs > Mental Health Professionals' Technology Usage a...

Links

Text available via DOI:

View graph of relations

Mental Health Professionals' Technology Usage and Attitudes Toward Digital Health for Psychosis: Comparative Cross-Sectional Survey Study

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Mental Health Professionals' Technology Usage and Attitudes Toward Digital Health for Psychosis: Comparative Cross-Sectional Survey Study. / Zhang, Xiaolong; Berry, Natalie; Di Basilio, Daniela et al.
In: JMIR Mental Health, Vol. 12, e68362, 31.03.2025.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Zhang X, Berry N, Di Basilio D, Richardson C, Eisner E, Bucci S. Mental Health Professionals' Technology Usage and Attitudes Toward Digital Health for Psychosis: Comparative Cross-Sectional Survey Study. JMIR Mental Health. 2025 Mar 31;12:e68362. doi: 10.2196/68362

Author

Bibtex

@article{91110274cc74489f835a017932f30c7a,
title = "Mental Health Professionals' Technology Usage and Attitudes Toward Digital Health for Psychosis: Comparative Cross-Sectional Survey Study",
abstract = "Digital health technologies (DHTs) for psychosis have been developed and tested rapidly in recent years. However, research examining mental health professionals' views on the use of DHTs for people with psychosis is limited. Given the increased accessibility and availability of DHTs for psychosis, an up-to-date understanding of staff perception of DHTs for psychosis is warranted. In this study, we aimed to investigate mental health professionals' usage of technology and their perception of service users' technology usage; their views toward the use of DHTs for psychosis, including their concerns; and barriers for implementing DHTs in a mental health setting. Two cross-sectional surveys were distributed to mental health care staff who had experience of working with individuals experiencing psychosis in the United Kingdom. Survey 1 (from April 2018 to September 2020) was distributed to 3 local UK National Health Service (NHS) trusts in Northwest England; survey 2 was administered nationally across 31 UK NHS trusts or health boards (from November 2022 to March 2024). The COVID-19 pandemic occurred between the 2 survey periods. Data were analyzed descriptively. A total of 155 and 352 participants completed surveys 1 and 2, respectively. Staff reported high levels of technology ownership and usage in both surveys. In general, staff expressed positive views regarding the use of DHTs for psychosis; however, barriers and concerns, including affordability, digital literacy, and potential negative effects on service users' mental health, were also reported. We did not find notable changes in terms of staff use of digital technology in clinical practice over time. Staff sampled from a broad and diverse range expressed consistent optimism about the potential implementation of DHTs in practice, though they also noted some concerns regarding safety and access. While the COVID-19 pandemic is frequently regarded as a catalyst for the adoption of digital health care tools, the sustainability of this transition from traditional to digital health care appeared to be suboptimal. To address staff concerns regarding safety and potentially facilitate the implementation of DHTs, systematic evaluation of adverse effects of using DHTs and dissemination of evidence are needed. Organizational support and training should be offered to staff to help address barriers and increase confidence in recommending and using DHTs with service users. ",
keywords = "Health Personnel - psychology, COVID-19 - epidemiology - psychology, Telemedicine, Cross-Sectional Studies, Male, Adult, Psychotic Disorders - therapy - psychology - epidemiology, Surveys and Questionnaires, digital mental health, Digital Health, psychosis, Female, Mental Health Services, Middle Aged, implementation, Attitude of Health Personnel, Digital Technology, smartphone app, attitudes, Humans, United Kingdom - epidemiology",
author = "Xiaolong Zhang and Natalie Berry and {Di Basilio}, Daniela and Cara Richardson and Emily Eisner and Sandra Bucci",
year = "2025",
month = mar,
day = "31",
doi = "10.2196/68362",
language = "English",
volume = "12",
journal = "JMIR Mental Health",
issn = "2368-7959",
publisher = "JMIR PUBLICATIONS, INC",

}

RIS

TY - JOUR

T1 - Mental Health Professionals' Technology Usage and Attitudes Toward Digital Health for Psychosis

T2 - Comparative Cross-Sectional Survey Study

AU - Zhang, Xiaolong

AU - Berry, Natalie

AU - Di Basilio, Daniela

AU - Richardson, Cara

AU - Eisner, Emily

AU - Bucci, Sandra

PY - 2025/3/31

Y1 - 2025/3/31

N2 - Digital health technologies (DHTs) for psychosis have been developed and tested rapidly in recent years. However, research examining mental health professionals' views on the use of DHTs for people with psychosis is limited. Given the increased accessibility and availability of DHTs for psychosis, an up-to-date understanding of staff perception of DHTs for psychosis is warranted. In this study, we aimed to investigate mental health professionals' usage of technology and their perception of service users' technology usage; their views toward the use of DHTs for psychosis, including their concerns; and barriers for implementing DHTs in a mental health setting. Two cross-sectional surveys were distributed to mental health care staff who had experience of working with individuals experiencing psychosis in the United Kingdom. Survey 1 (from April 2018 to September 2020) was distributed to 3 local UK National Health Service (NHS) trusts in Northwest England; survey 2 was administered nationally across 31 UK NHS trusts or health boards (from November 2022 to March 2024). The COVID-19 pandemic occurred between the 2 survey periods. Data were analyzed descriptively. A total of 155 and 352 participants completed surveys 1 and 2, respectively. Staff reported high levels of technology ownership and usage in both surveys. In general, staff expressed positive views regarding the use of DHTs for psychosis; however, barriers and concerns, including affordability, digital literacy, and potential negative effects on service users' mental health, were also reported. We did not find notable changes in terms of staff use of digital technology in clinical practice over time. Staff sampled from a broad and diverse range expressed consistent optimism about the potential implementation of DHTs in practice, though they also noted some concerns regarding safety and access. While the COVID-19 pandemic is frequently regarded as a catalyst for the adoption of digital health care tools, the sustainability of this transition from traditional to digital health care appeared to be suboptimal. To address staff concerns regarding safety and potentially facilitate the implementation of DHTs, systematic evaluation of adverse effects of using DHTs and dissemination of evidence are needed. Organizational support and training should be offered to staff to help address barriers and increase confidence in recommending and using DHTs with service users.

AB - Digital health technologies (DHTs) for psychosis have been developed and tested rapidly in recent years. However, research examining mental health professionals' views on the use of DHTs for people with psychosis is limited. Given the increased accessibility and availability of DHTs for psychosis, an up-to-date understanding of staff perception of DHTs for psychosis is warranted. In this study, we aimed to investigate mental health professionals' usage of technology and their perception of service users' technology usage; their views toward the use of DHTs for psychosis, including their concerns; and barriers for implementing DHTs in a mental health setting. Two cross-sectional surveys were distributed to mental health care staff who had experience of working with individuals experiencing psychosis in the United Kingdom. Survey 1 (from April 2018 to September 2020) was distributed to 3 local UK National Health Service (NHS) trusts in Northwest England; survey 2 was administered nationally across 31 UK NHS trusts or health boards (from November 2022 to March 2024). The COVID-19 pandemic occurred between the 2 survey periods. Data were analyzed descriptively. A total of 155 and 352 participants completed surveys 1 and 2, respectively. Staff reported high levels of technology ownership and usage in both surveys. In general, staff expressed positive views regarding the use of DHTs for psychosis; however, barriers and concerns, including affordability, digital literacy, and potential negative effects on service users' mental health, were also reported. We did not find notable changes in terms of staff use of digital technology in clinical practice over time. Staff sampled from a broad and diverse range expressed consistent optimism about the potential implementation of DHTs in practice, though they also noted some concerns regarding safety and access. While the COVID-19 pandemic is frequently regarded as a catalyst for the adoption of digital health care tools, the sustainability of this transition from traditional to digital health care appeared to be suboptimal. To address staff concerns regarding safety and potentially facilitate the implementation of DHTs, systematic evaluation of adverse effects of using DHTs and dissemination of evidence are needed. Organizational support and training should be offered to staff to help address barriers and increase confidence in recommending and using DHTs with service users.

KW - Health Personnel - psychology

KW - COVID-19 - epidemiology - psychology

KW - Telemedicine

KW - Cross-Sectional Studies

KW - Male

KW - Adult

KW - Psychotic Disorders - therapy - psychology - epidemiology

KW - Surveys and Questionnaires

KW - digital mental health

KW - Digital Health

KW - psychosis

KW - Female

KW - Mental Health Services

KW - Middle Aged

KW - implementation

KW - Attitude of Health Personnel

KW - Digital Technology

KW - smartphone app

KW - attitudes

KW - Humans

KW - United Kingdom - epidemiology

U2 - 10.2196/68362

DO - 10.2196/68362

M3 - Journal article

C2 - 40163639

VL - 12

JO - JMIR Mental Health

JF - JMIR Mental Health

SN - 2368-7959

M1 - e68362

ER -